SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001144204-14-012240
Filing Date
2014-02-28
Accepted
2014-02-27 19:59:36
Documents
1
Group Members
DAVID L. DOUGLASSDEEPIKA R. PAKIANATHAN, PH.D.DELPHI BIOINVESTMENTS VII, L.P.DELPHI MANAGEMENT PARTNERS VII, L.L.C.DOUGLAS A. ROEDERJAMES J. BOCHNOWSKI

Document Format Files

Seq Description Document Type Size
1 SC 13G v369980_sc13g.htm SC 13G 126498
  Complete submission text file 0001144204-14-012240.txt   128143
Mailing Address 3000 SAND HILL RD BUILDING 1 SUITE 135 MENLO PARK CA 94025
Business Address 3000 SAND HILL RD BUILDING 1 SUITE 135 MENLO PARK CA 94025 650-854-9650
DELPHI VENTURES VII L P (Filed by) CIK: 0001336922 (see all company filings)

IRS No.: 000000000
Type: SC 13G

Mailing Address 700 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 700 SAGINAW DRIVE REDWOOD CITY CA 94063 650-421-9500
Relypsa Inc (Subject) CIK: 0001416792 (see all company filings)

IRS No.: 260893742 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87732 | Film No.: 14651078
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences